Kurt Quitzau

957 total citations
11 papers, 459 citations indexed

About

Kurt Quitzau is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Kurt Quitzau has authored 11 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Kurt Quitzau's work include Cardiac Imaging and Diagnostics (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Kurt Quitzau is often cited by papers focused on Cardiac Imaging and Diagnostics (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Kurt Quitzau collaborates with scholars based in Switzerland, Germany and Denmark. Kurt Quitzau's co-authors include Thomas F. Lüscher, Frank Ruschitzka, Thomas Notter, John J.V. McMurray, Jay N. Cohn, Marvin A. Konstam, Inder S. Anand, Matthias Hermann, Rainer H. Böger and Thomas Münzel and has published in prestigious journals such as The Lancet, Scientific Reports and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Kurt Quitzau

10 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Quitzau Switzerland 8 309 164 101 58 44 11 459
Tjin L. Njo Netherlands 15 96 0.3× 99 0.6× 126 1.2× 85 1.5× 56 1.3× 24 484
Janet V. Johnson United States 7 347 1.1× 33 0.2× 89 0.9× 97 1.7× 28 0.6× 7 502
Eugene C. Lozner United States 9 296 1.0× 103 0.6× 38 0.4× 181 3.1× 45 1.0× 12 628
Paweł Siwołowski Poland 12 343 1.1× 92 0.6× 44 0.4× 39 0.7× 38 0.9× 19 458
Takashi Kajiya Japan 10 142 0.5× 161 1.0× 28 0.3× 136 2.3× 36 0.8× 33 389
I Weinberger Israel 15 285 0.9× 132 0.8× 26 0.3× 158 2.7× 53 1.2× 50 637
Sylwia Nawrocka‐Millward Poland 9 259 0.8× 84 0.5× 36 0.4× 34 0.6× 37 0.8× 10 359
Wojciech Jacheć Poland 18 673 2.2× 97 0.6× 41 0.4× 198 3.4× 86 2.0× 112 925
Gustavo Neves de Araújo Brazil 11 142 0.5× 66 0.4× 35 0.3× 90 1.6× 38 0.9× 40 427
Milind Hote India 13 222 0.7× 74 0.5× 21 0.2× 127 2.2× 74 1.7× 72 401

Countries citing papers authored by Kurt Quitzau

Since Specialization
Citations

This map shows the geographic impact of Kurt Quitzau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Quitzau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Quitzau more than expected).

Fields of papers citing papers by Kurt Quitzau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Quitzau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Quitzau. The network helps show where Kurt Quitzau may publish in the future.

Co-authorship network of co-authors of Kurt Quitzau

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Quitzau. A scholar is included among the top collaborators of Kurt Quitzau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Quitzau. Kurt Quitzau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mahmoudpour, Seyed Hamidreza, Luca Valerio, Christian Becker, et al.. (2019). Safety of low-dose subcutaneous recombinant interleukin-2: systematic review and meta-analysis of randomized controlled trials. Scientific Reports. 9(1). 7145–7145. 17 indexed citations
2.
Barco, Stefano, Mareike Lankeit, Harald Binder, et al.. (2016). Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Thrombosis and Haemostasis. 116(7). 191–197. 28 indexed citations
3.
Hermann, Matthias, Dieter Fischer, Michael M. Hoffmann, et al.. (2011). CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease – IVUS substudy of the ENCORE trials. Atherosclerosis. 220(1). 172–176. 20 indexed citations
4.
Hermann, Matthias, Jens Hellermann, Kurt Quitzau, et al.. (2009). CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease—The ENCORE Trials. Atherosclerosis. 207(2). 476–479. 23 indexed citations
5.
Flammer, Andreas J., Bruno Ledergerber, Matthias Hermann, et al.. (2008). Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial. Heart. 95(5). 385–390. 37 indexed citations
6.
Maas, Renke, Kurt Quitzau, Edzard Schwedhelm, et al.. (2006). Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia. Atherosclerosis. 191(1). 211–219. 37 indexed citations
7.
8.
Lüscher, Thomas F., T. Meinertz, Andreas M. Zeiher, et al.. (2000). Functional impairment of visually non- or minimally atherosclerotic coronary arteries Insight from the ENCORE trial. 514.
9.
Luescher, T F, Philip Hugenholtz, Kurt Quitzau, et al.. (1997). 内皮機能及びアテローム性動脈硬化症に対するカルシウム遮断薬及びHMG-補酵素レダクターゼ阻害の影響 ENCORE治験の論理的根拠と概略. Journal of Cardiovascular Pharmacology. 30. 48–52. 1 indexed citations
10.
Christophersen, J, et al.. (1989). Treating genitourinary and pharyngeal gonorrhoea with single dose ceftriaxone.. Sexually Transmitted Infections. 65(1). 14–17. 6 indexed citations
11.
Korsager, Birgitte, et al.. (1988). Fleroxacin in the treatment of uncomplicated acute cystitis in women. Journal of Antimicrobial Chemotherapy. 22(Supplement_D). 215–218. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tjin L. Njo Breakdown of academic impact, for papers by Janet V. Johnson Breakdown of academic impact, for papers by Eugene C. Lozner Breakdown of academic impact, for papers by Paweł Siwołowski Breakdown of academic impact, for papers by Takashi Kajiya Breakdown of academic impact, for papers by I Weinberger Breakdown of academic impact, for papers by Sylwia Nawrocka‐Millward Breakdown of academic impact, for papers by Wojciech Jacheć Breakdown of academic impact, for papers by Gustavo Neves de Araújo Breakdown of academic impact, for papers by Milind Hote
Rankless by CCL
2026